Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Raffinose.
Raffinose is a non-digestible trisaccharide that functions as a selective prebiotic, promoting the proliferation of beneficial gut microbiota while modulating glycemic response and intestinal barrier function.
10542
504.4 g/mol
-5.8
(3R,4S,5R,6R)-2-[[(2R,3S,4S,5R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Raffinose across standard consumer modalities.
The hygroscopic nature of raffinose necessitates low-moisture HPMC shells and desiccants to prevent powder caking and ensure shelf stability.
Incorporating effective prebiotic doses of raffinose can disrupt the hydrogen bonding in pectin matrices, resulting in syneresis or compromised structural integrity.
The high therapeutic dose required for prebiotic activity exceeds the typical 20-50mg payload capacity of thin-film oral delivery systems.
Ready to launch a product featuring Raffinose? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Raffinose extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Raffinose payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation